Contemporary treatment of pulmonary arterial hypertension: the North-West Registry data analysis
Aim. Using the prospective Registry data, to assess the effects of conventional and specific therapy on the clinical course and survival of the patients with pulmonary arterial hypertension (PAH). Material and methods. The study included 124 patients (mean age 38,2±13,7 years; 34 men and 78 women):...
Saved in:
Main Authors: | N. S. Goncharova, A. V. Kazymly, A. V. Naimushin, O. M. Moiseeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2012-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1878 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01) -
Idiopathic pulmonary arterial hypertension and congenital heart defects: similarities and differences
by: E. A. Devetyarova, et al.
Published: (2025-03-01) -
Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension)
by: E. L. Trisvetova, et al.
Published: (2016-03-01) -
THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01) -
MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION
by: T. V. Martynyuk, et al.
Published: (2020-06-01)